Victrex (LON:VCT) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened

Shares of Victrex plc (LON:VCT - Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 998.70 ($12.22) and traded as high as GBX 1,056 ($12.92). Victrex shares last traded at GBX 1,046 ($12.80), with a volume of 28,260,615 shares.

Analysts Set New Price Targets

Separately, Berenberg Bank dropped their price objective on Victrex from GBX 1,290 ($15.78) to GBX 1,170 ($14.32) and set a "hold" rating on the stock in a report on Wednesday, December 4th.

Victrex Stock Up 1.7 %

The firm has a market capitalization of £924.26 million, a price-to-earnings ratio of 3,034.29, a price-to-earnings-growth ratio of 1.92 and a beta of 0.69. The business has a 50 day moving average of GBX 1,000.34 and a 200 day moving average of GBX 997.85. The company has a debt-to-equity ratio of 16.99, a current ratio of 5.30 and a quick ratio of 1.99.

Victrex Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, February 21st. Investors of record on Thursday, January 23rd will be given a GBX 46.14 ($0.56) dividend. This is a boost from Victrex's previous dividend of $13.42. This represents a yield of 5.26%. The ex-dividend date is Thursday, January 23rd. Victrex's dividend payout ratio (DPR) is 17,142.86%.

Insider Transactions at Victrex

In other news, insider Ian Melling acquired 2,000 shares of the firm's stock in a transaction on Friday, December 13th. The shares were purchased at an average cost of GBX 1,135 ($13.89) per share, with a total value of £22,700 ($27,774.38). Also, insider Brendan Connolly purchased 980 shares of the company's stock in a transaction that occurred on Tuesday, December 3rd. The shares were acquired at an average cost of GBX 1,019 ($12.47) per share, with a total value of £9,986.20 ($12,218.52). 1.64% of the stock is owned by insiders.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.